Information on the Target

Tene Capital has successfully sold its stake in Sharon Personal Care (SPC), a prominent division of Sharon Laboratories Group focused on cosmetics, to Eternis Fine Chemicals, Ltd. Established in 1977, Sharon Laboratories Group specializes in developing, producing, and marketing ingredients across the food, baking, and cosmetics industries. The cosmetics division was launched in 1992 and has evolved to become a leader in crafting preservation systems for cosmetic formulations.

Under Tene's stewardship, which began with a significant investment in 2017 where they acquired around 60% of the Group for approximately $40 million, SPC transitioned towards pioneering preservation technologies emphasizing natural and

View Original Article

Similar Deals

BIC Tangle Teezer

2024

Management Buyout (MBO) Personal & Household Products & Services United Kingdom
Chin Family Organika Health Products, Inc.

2024

Management Buyout (MBO) Personal & Household Products & Services Canada
Swander Pace Capital GilChrist & Soames

2023

Management Buyout (MBO) Personal & Household Products & Services United States of America
Mason Wells Onyx Brands, Inc.

2023

Management Buyout (MBO) Personal & Household Products & Services United States of America
PPC Flexible Packaging MAPfresh Holdings (StePac)

2023

Management Buyout (MBO) Food & Drug Retailing Israel
PPC Flexible Packaging StePac

2023

Management Buyout (MBO) Containers & Packaging Israel
Castanea Partners Urban Decay Cosmetics, LLC

2023

Management Buyout (MBO) Personal & Household Products & Services United States of America
IDI Prévost Laboratory Concept

2023

Management Buyout (MBO) Personal & Household Products & Services France
Polexandre Joly Remanence

2023

Management Buyout (MBO) Personal & Household Products & Services France
Advantage Partners Quality First

2023

Management Buyout (MBO) Personal & Household Products & Services Japan

Eternis Fine Chemicals, Ltd.

invested in

Sharon Personal Care

in 2024

in a Management Buyout (MBO) deal

Disclosed details

Revenue: $250M

Equity Value: $40M


Multiples

P/Revenue: 0.2x

Deal Parametres
Industry
Country
Seller type

Sign Up to Dealert